{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [{"AbstractText": ["L\u2019anxi\u00e9t\u00e9 de s\u00e9paration et une aversion au bruit sont des probl\u00e8mes de comportement fr\u00e9quents chez les chiens. Elles \u00e9licitent des r\u00e9ponses de peur telles que des tremblements, la recherche du propri\u00e9taire, et une tentative de fuite. Elles peuvent r\u00e9sulter en des dommages \u00e0 la propri\u00e9t\u00e9, des blessures au chien, et un bris du lien propri\u00e9taire-animal, pouvant potentiellement mener \u00e0 l\u2019abandon de l\u2019animal ou l\u2019euthanasie. Un nouveau produit anxiolytique botanique a \u00e9t\u00e9 \u00e9valu\u00e9 pour sa s\u00e9curit\u00e9 chez les chiens, l\u2019esp\u00e8ce animale cible. Son utilisation vis\u00e9e est pour le traitement et la pr\u00e9vention de l\u2019anxi\u00e9t\u00e9 et de l\u2019aversion au bruit chez les chiens. Le produit contient un m\u00e9lange d\u00e9fini de vigne de <i>Souroubea</i> spp. et d\u2019\u00e9corce de <i>Platanus</i> spp., fournissant le principe actif, l\u2019acide b\u00e9tulinique, \u00e0 un dosage recommand\u00e9 de 1 mg/kg de poids corporel (PC). Dans l\u2019\u00e9tude de s\u00e9curit\u00e9 chez l\u2019esp\u00e8ce animale cible, 16 chiens m\u00e2les de race beagle en sant\u00e9 ont re\u00e7u soit un placebo ou les nouvelles tablettes botaniques \u00e0 0,5\u00d7, 2,5\u00d7, ou 5\u00d7 la dose recommand\u00e9e (1 mg/kg PC) pendant 28 jours. Les chiens ont \u00e9t\u00e9 observ\u00e9s pour l\u2019apparition de manifestions adverses syst\u00e9miques ou locales. Dans l\u2019\u00e9tude pr\u00e9sent\u00e9e ici, il n\u2019y eut aucun effet clinique adverse significatif suivant le traitement, tel que d\u00e9termin\u00e9 par les observations cliniques, les examens physiques, le PC, et les r\u00e9sultats des analyses h\u00e9matologiques, de biochimie clinique et urinaires. L\u2019analyse pharmacocin\u00e9tique a d\u00e9montr\u00e9 que la concentration d\u2019acide b\u00e9tulinique dans le s\u00e9rum \u00e9tait moins de 0,020 \u03bcg/mL chez les animaux trait\u00e9s. Dans les conditions des pr\u00e9sentes \u00e9tudes, le m\u00e9lange de <i>S. sympetala</i> et de <i>P. occidentalis,</i> lorsqu\u2019administr\u00e9 jusqu\u2019\u00e0 5\u00d7 le dosage pr\u00e9vu pendant 28 jours cons\u00e9cutifs, n\u2019a d\u00e9montr\u00e9 aucun effet adverse sur la sant\u00e9 des chiens.(Traduit par Docteur Serge Messier)."]}], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "29382964", "DateCompleted": {"Year": "2018", "Month": "08", "Day": "13"}, "DateRevised": {"Year": "2022", "Month": "12", "Day": "07"}, "Article": {"ArticleDate": [], "Language": ["eng"], "ELocationID": [], "Journal": {"ISSN": "1928-9022", "JournalIssue": {"Volume": "82", "Issue": "1", "PubDate": {"Year": "2018", "Month": "Jan"}}, "Title": "Canadian journal of veterinary research = Revue canadienne de recherche veterinaire", "ISOAbbreviation": "Can J Vet Res"}, "ArticleTitle": "Safety evaluation of a new anxiolytic product containing botanicals <i>Souroubea</i> spp. and <i>Platanus</i> spp. in dogs.", "Pagination": {"StartPage": "3", "EndPage": "11", "MedlinePgn": "3-11"}, "Abstract": {"AbstractText": ["Separation anxiety and noise aversion are common behavioral problems in dogs. They elicit fear responses such as cowering, seeking out the owner, and attempting to escape. This can result in property damage, injury to the dog, and disruption of the owner-pet bond, possibly leading to pet abandonment or euthanasia. A novel botanical anxiolytic product was evaluated for safety in dogs as the target animal species. Its intended use is for the treatment and prevention of anxiety and noise aversion in dogs. It contains a defined mixture of <i>Souroubea</i> spp. vine and <i>Platanus</i> spp. bark, delivering the active principle, betulinic acid, at a recommended dose of 1 mg/kg body weight (BW). In the current target animal safety study, 16 healthy male beagle dogs were administered either a placebo or the newly formulated botanical tablets at 0.5\u00d7, 2.5\u00d7, or 5\u00d7 the recommended dose (1 mg/kg BW) over 28 d. The dogs were monitored for occurrence of any systemic or local adverse events. In the investigation presented here, there were no clinically significant adverse effects following treatment, as determined by clinical observations, physical examinations, BW, hematology, clinical biochemistry, and urinalysis. Pharmacokinetic analysis demonstrated that the concentration of betulinic acid in serum was below 0.020 \u03bcg/mL in treated animals. Under the conditions of these studies, the formulated blend of <i>S. sympetala</i> and <i>P. occidentalis,</i> when administered up to 5\u00d7 the intended dose for 28 consecutive d, showed no adverse effects on the health of dogs."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Cancog Tecnologies, 120 Carlton Street, Toronto, Ontario M5A 4K2, Canada (Masic); Faculty of Science, University of Ottawa, Ottawa, Ontario K1N 6N5 (Liu, Saleem, Harris, Durst, Arnason); Novometrix Research, Moffat, Ontario L0P 1J0 (Simkus, Wilson); Stonehedge Bioresources, Stirling, Ontario (Baker); Universidad Nacional, Heredia, Costa Rica (Sanchez)."}], "LastName": "Masic", "ForeName": "Aleksandar", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Cancog Tecnologies, 120 Carlton Street, Toronto, Ontario M5A 4K2, Canada (Masic); Faculty of Science, University of Ottawa, Ottawa, Ontario K1N 6N5 (Liu, Saleem, Harris, Durst, Arnason); Novometrix Research, Moffat, Ontario L0P 1J0 (Simkus, Wilson); Stonehedge Bioresources, Stirling, Ontario (Baker); Universidad Nacional, Heredia, Costa Rica (Sanchez)."}], "LastName": "Liu", "ForeName": "Rui", "Initials": "R"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Cancog Tecnologies, 120 Carlton Street, Toronto, Ontario M5A 4K2, Canada (Masic); Faculty of Science, University of Ottawa, Ottawa, Ontario K1N 6N5 (Liu, Saleem, Harris, Durst, Arnason); Novometrix Research, Moffat, Ontario L0P 1J0 (Simkus, Wilson); Stonehedge Bioresources, Stirling, Ontario (Baker); Universidad Nacional, Heredia, Costa Rica (Sanchez)."}], "LastName": "Simkus", "ForeName": "Kristen", "Initials": "K"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Cancog Tecnologies, 120 Carlton Street, Toronto, Ontario M5A 4K2, Canada (Masic); Faculty of Science, University of Ottawa, Ottawa, Ontario K1N 6N5 (Liu, Saleem, Harris, Durst, Arnason); Novometrix Research, Moffat, Ontario L0P 1J0 (Simkus, Wilson); Stonehedge Bioresources, Stirling, Ontario (Baker); Universidad Nacional, Heredia, Costa Rica (Sanchez)."}], "LastName": "Wilson", "ForeName": "Jeff", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Cancog Tecnologies, 120 Carlton Street, Toronto, Ontario M5A 4K2, Canada (Masic); Faculty of Science, University of Ottawa, Ottawa, Ontario K1N 6N5 (Liu, Saleem, Harris, Durst, Arnason); Novometrix Research, Moffat, Ontario L0P 1J0 (Simkus, Wilson); Stonehedge Bioresources, Stirling, Ontario (Baker); Universidad Nacional, Heredia, Costa Rica (Sanchez)."}], "LastName": "Baker", "ForeName": "John", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Cancog Tecnologies, 120 Carlton Street, Toronto, Ontario M5A 4K2, Canada (Masic); Faculty of Science, University of Ottawa, Ottawa, Ontario K1N 6N5 (Liu, Saleem, Harris, Durst, Arnason); Novometrix Research, Moffat, Ontario L0P 1J0 (Simkus, Wilson); Stonehedge Bioresources, Stirling, Ontario (Baker); Universidad Nacional, Heredia, Costa Rica (Sanchez)."}], "LastName": "Sanchez", "ForeName": "Pablo", "Initials": "P"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Cancog Tecnologies, 120 Carlton Street, Toronto, Ontario M5A 4K2, Canada (Masic); Faculty of Science, University of Ottawa, Ottawa, Ontario K1N 6N5 (Liu, Saleem, Harris, Durst, Arnason); Novometrix Research, Moffat, Ontario L0P 1J0 (Simkus, Wilson); Stonehedge Bioresources, Stirling, Ontario (Baker); Universidad Nacional, Heredia, Costa Rica (Sanchez)."}], "LastName": "Saleem", "ForeName": "Ammar", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Cancog Tecnologies, 120 Carlton Street, Toronto, Ontario M5A 4K2, Canada (Masic); Faculty of Science, University of Ottawa, Ottawa, Ontario K1N 6N5 (Liu, Saleem, Harris, Durst, Arnason); Novometrix Research, Moffat, Ontario L0P 1J0 (Simkus, Wilson); Stonehedge Bioresources, Stirling, Ontario (Baker); Universidad Nacional, Heredia, Costa Rica (Sanchez)."}], "LastName": "Harris", "ForeName": "Cory C", "Initials": "CC"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Cancog Tecnologies, 120 Carlton Street, Toronto, Ontario M5A 4K2, Canada (Masic); Faculty of Science, University of Ottawa, Ottawa, Ontario K1N 6N5 (Liu, Saleem, Harris, Durst, Arnason); Novometrix Research, Moffat, Ontario L0P 1J0 (Simkus, Wilson); Stonehedge Bioresources, Stirling, Ontario (Baker); Universidad Nacional, Heredia, Costa Rica (Sanchez)."}], "LastName": "Durst", "ForeName": "Tony", "Initials": "T"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Cancog Tecnologies, 120 Carlton Street, Toronto, Ontario M5A 4K2, Canada (Masic); Faculty of Science, University of Ottawa, Ottawa, Ontario K1N 6N5 (Liu, Saleem, Harris, Durst, Arnason); Novometrix Research, Moffat, Ontario L0P 1J0 (Simkus, Wilson); Stonehedge Bioresources, Stirling, Ontario (Baker); Universidad Nacional, Heredia, Costa Rica (Sanchez)."}], "LastName": "Arnason", "ForeName": "John T", "Initials": "JT"}], "PublicationTypeList": ["Journal Article", "Randomized Controlled Trial"]}, "MedlineJournalInfo": {"Country": "Canada", "MedlineTA": "Can J Vet Res", "NlmUniqueID": "8607793", "ISSNLinking": "0830-9000"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Anti-Anxiety Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Pentacyclic Triterpenes"}, {"RegistryNumber": "0", "NameOfSubstance": "Plant Preparations"}, {"RegistryNumber": "0", "NameOfSubstance": "Triterpenes"}, {"RegistryNumber": "4G6A18707N", "NameOfSubstance": "Betulinic Acid"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["adverse effects"], "DescriptorName": "Anti-Anxiety Agents"}, {"QualifierName": [], "DescriptorName": "Dogs"}, {"QualifierName": [], "DescriptorName": "Double-Blind Method"}, {"QualifierName": ["chemistry"], "DescriptorName": "Ericales"}, {"QualifierName": ["chemistry"], "DescriptorName": "Magnoliopsida"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": [], "DescriptorName": "Pentacyclic Triterpenes"}, {"QualifierName": ["chemistry"], "DescriptorName": "Plant Bark"}, {"QualifierName": ["adverse effects"], "DescriptorName": "Plant Preparations"}, {"QualifierName": ["chemistry"], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": ["adverse effects", "blood", "pharmacokinetics"], "DescriptorName": "Triterpenes"}, {"QualifierName": [], "DescriptorName": "Betulinic Acid"}], "CoiStatement": "Competing interests Financial support was provided by Bioniche Life Sciences to Novometrix Research and to Paul Dick and Associates for their work. Since the corporate reorganization of Bioniche Life Sciences, leading to the sale of veterinary technologies, the product has been licensed to Souroubea Botanicals and several of the authors are principals in the new company (Arnason, Baker, Durst, Sanchez). Dr. Masic was employed by Bioniche Life Sciences at the time of study execution."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Sherman BL, Mills DS. Canine anxieties and phobias: An update on separation anxiety and noise aversions. Vet Clin North Am Small Anim Pract. 2008;38:1081\u20131106.", "ArticleIdList": ["18672155"]}, {"Citation": "Shull-Selcer EA, Stagg W. Advances in the understanding and treatment of noise phobias. Vet Clin North Am Small Anim Pract. 1991;21:353\u2013367.", "ArticleIdList": ["2053256"]}, {"Citation": "Thompson SB. Pharmacologic treatment of phobias. In: Dodman NH, Shuster L, editors. Psychopharmacology of Animal Behavior Disorders. Malden, Massachusetts: Blackwell Science; 1998. pp. 141\u2013182."}, {"Citation": "Dreschel NA. The effects of fear and anxiety on health and lifespan in pet dogs. Appl Anim Behav Sci. 2010;125:157\u2013162."}, {"Citation": "Puniani E, Cayer C, Kent P, et al. Ethnopharmacology of Souroubea sympetala and Souroubea gilgii (Marcgraviaceae) and identification of betulinic acid as an anxiolytic principle. Phytochemistry. 2015;113:73\u201378.", "ArticleIdList": ["24641939"]}, {"Citation": "Mullally M, Kramp K, Cayer C, et al. Anxiolytic activity of a supercritical carbon dioxide extract of Souroubea sympetala. Phytother Res. 2011;25:264\u2013270.", "ArticleIdList": ["20648677"]}, {"Citation": "Carballo-Arce AF. PhD dissertation. Ottawa, Ontario: University of Ottawa; 2013. Phytochemical investigations of Costa Rican Marcgraviaceae and development of insecticide synergists."}, {"Citation": "Cayer C. MSc dissertation. Ottawa, Ontario: University of Ottawa; 2011. In vivo behavioural characterization of anxiolytic botanicals."}, {"Citation": "Mullally M, Cayer C, Kramp K, et al. Souroubea sympetala (Marcgraviaceae): A medicinal plant that exerts anxiolysis through interaction with the GABAA benzodiazepine receptor. Can J Physiol Pharmacol. 2014;92:758\u2013764.", "ArticleIdList": ["25140794"]}, {"Citation": "Mullally M. PhD dissertation. Ottawa, Ontario: University of Ottawa; 2011. Anxiety-reducing tropical plants: Phytochemical and pharmacological characterization of Souroubea sympetala and Piper amalago."}, {"Citation": "Fujioka T, Kashiwada Y, Kilkuskie RE, et al. Anti-AIDS agents, 11. Betulinic acid and platanic acid as anti-HIV principles from Syzigium claviflorum, and the anti-HIV activity of structurally related triterpenoids. J Nat Prod. 1994;57:243\u2013247.", "ArticleIdList": ["8176401"]}, {"Citation": "Kashiwada Y, Hashimoto F, Cosentino LM, Chen CH, Garrett PE, Lee KH. Betulinic acid and dihydrobetulinic acid derivatives as potent anti-HIV agents. J Med Chem. 1996;39:1016\u20131017.", "ArticleIdList": ["8676334"]}, {"Citation": "Mayaux JF, Bousseau A, Pauwels R, et al. Triterpene derivatives that block entry of human immunodeficiency virus type 1 into cells. Proc Natl Acad Sci USA. 1994;91:3564\u20133568.", "ArticleIdList": ["PMC43620", "8170948"]}, {"Citation": "Mukherjee PK, Saha K, Das J, Pal M, Saha BP. Studies on the anti-inflammatory activity of rhizomes of Nelumbo nucifera. Planta Med. 1997;63:367\u2013369.", "ArticleIdList": ["9270384"]}, {"Citation": "Recio MC, Giner RM, M\u00e1\u00f1ez S, et al. Investigations on the steroidal anti-inflammatory activity of triterpenoids from Diospyros leucomelas. Planta Med. 1995;61:9\u201312.", "ArticleIdList": ["7701004"]}, {"Citation": "Pisha E, Chai H, Lee IS, et al. Discovery of betulinic acid as a selective inhibitor of human melanoma that functions by induction of apoptosis. Nat Med. 1995;1:1046\u20131051.", "ArticleIdList": ["7489361"]}, {"Citation": "Selzer E, Pimentel E, Wacheck V, et al. Effects of betulinic acid alone and in combination with irradiation in human melanoma cells. J Invest Dermatol. 2000;114:935\u2013940.", "ArticleIdList": ["10771474"]}, {"Citation": "Zuco V, Supino R, Righetti SC, et al. Selective cytotoxicity of betulinic acid on tumor cell lines, but not on normal cells. Cancer Lett. 2002;175:17\u201325.", "ArticleIdList": ["11734332"]}, {"Citation": "Fulda S, Debatin KM. Betulinic acid induces apoptosis through a direct effect on mitochondria in neuroectodermal tumors. Med Pediatr Oncol. 2000;35:616\u2013618.", "ArticleIdList": ["11107130"]}, {"Citation": "Ramadoss S, Jaggi M, Siddiqui MJA. Use of betulinic acid and its derivatives for inhibiting cancer growth and a method of monitoring this. 6048847. U.S. Patent. A filed March 18, 1998 and issued April 11, 2000."}, {"Citation": "Sch\u00fchly W, Heilmann J, Calis I, Sticher O. New triterpenoids with antibacterial activity from Zizyphus joazerio. Planta Med. 1999;65:740\u2013743.", "ArticleIdList": ["10630117"]}, {"Citation": "Chandramu C, Manohar RD, Krupadanam DG, Dashavantha RV. Isolation, characterization and biological activity of betulinic acid and ursolic acid from Vitex negundo L. Phytother Res. 2003;17:129\u2013134.", "ArticleIdList": ["12601674"]}, {"Citation": "Schultes RE, Raffauf RF. The Healing Forest: Medicinal and Toxic Plants of the Northwest Amazonia. Portland, Oregon: Dioscorides Press; 1990."}, {"Citation": "Bourbonnais-Spear N, Awad R, Merali Z, Maquin P, Cal V, Arnason JT. Ethnopharmacological investigation of plants used to treat susto, a folk illness. J Ethnopharmacol. 2007;109:380\u2013387.", "ArticleIdList": ["17071033"]}, {"Citation": "Bourbonnais-Spear N, Poissant J, Cal V, Arnason JT. Culturally important plants from southern Belize: Domestication by Q\u2019eqchi\u2019 Maya healers and conservation. Ambio. 2006;35:138\u2013140.", "ArticleIdList": ["16846204"]}, {"Citation": "Arnason T, Hebda RJ, Johns T. Use of plants for food and medicine by Native Peoples of eastern Canada. Can J Bot. 1981;59:2189\u20132325."}, {"Citation": "Hamel PB, Chiltoskey MU. Cherokee Plants and Their Uses: A 400 Year History. Sylva, NC: Herald Publishing; 1975. pp. 1\u201352."}, {"Citation": "Villalobos P, Baker J, Sanchez Vindas P, Durst T, Masic A, Arnason JT. Clinical observations and safety profile of oral herbal products, Souroubea and Platanus spp: A pilot-toxicology study in dogs. Acta Vet. 2014;64:269\u2013275."}, {"Citation": "Godugu C, Patel AR, Doddapaneni R, Somagoni J, Singh M. Approaches to improve the oral bioavailability and effects of novel anticancer drugs berberine and betulinic acid. PLoS ONE. 2014;9:e89919.", "ArticleIdList": ["PMC3948684", "24614362"]}, {"Citation": "Udeani GO, Zhao GM, Geun Shin Y, et al. Pharmacokinetics and tissue distribution of betulinic acid in CD-1 mice. Biopharm Drug Dispos. 1999;20:379\u2013383.", "ArticleIdList": ["10870094"]}]}], "History": [{"Year": "2017", "Month": "4", "Day": "10"}, {"Year": "2017", "Month": "6", "Day": "9"}, {"Year": "2018", "Month": "2", "Day": "1", "Hour": "6", "Minute": "0"}, {"Year": "2018", "Month": "2", "Day": "1", "Hour": "6", "Minute": "0"}, {"Year": "2018", "Month": "8", "Day": "14", "Hour": "6", "Minute": "0"}, {"Year": "2018", "Month": "7", "Day": "1"}], "PublicationStatus": "ppublish", "ArticleIdList": ["29382964", "PMC5764046"]}}]}